Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Role of Potassium and Calcium Ions in the Effect of Epinephrine on Cardiac Cyclic Adenosine 3',5'-Monophosphate, Phosphorylase Kinase, and Phosphorylase

DONALD H. NAMM, STEVEN E. MAYER and MARGARET MALTBIE
Molecular Pharmacology September 1968, 4 (5) 522-530;
DONALD H. NAMM
Department of Pharmacology, Division of Basic Health Sciences, Emory University, Atlanta, Georgia 3O322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEVEN E. MAYER
Department of Pharmacology, Division of Basic Health Sciences, Emory University, Atlanta, Georgia 3O322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARGARET MALTBIE
Department of Pharmacology, Division of Basic Health Sciences, Emory University, Atlanta, Georgia 3O322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effect of epinephrine on the biochemical sequence of events leading to the activation of glycogen phosphorylase was studied in the isolated, perfused rat heart. In arrested preparations, perfused with a medium either devoid of Ca++ or containing a depolarizing concentration of K+, the epinephrine-induced activation of phosphorylase was markedly diminished. In the absence of Ca++, however, the epinephrine-induced rise in cyclic adenosine 3',5'-monophosphate (cyclic AMP) concentration and the activation of phosphorylase kinase were not greatly altered. This suggested that the effect of omission of Ca++ occurred at the phosphorylase b to a conversion step.

The effect of epinephrine on phosphorylase activation was blocked simultaneously with the cessation of contraction following perfusion with a Ca++-deficient medium. The store of Ca++ required for the maintenance of contractile activity appeared to be similar to that necessary for the conversion of phosphorylase b to a.

Elevation of Ca++ in the perfusion medium resulted in activation of phosphorylase but not of phosphorylase kinase; nor was there an increase in cyclic AMP concentration. This observation also suggested that Ca++ is required for the catalytic activity of phosphorylase kinase.

In the heart depolarized with K+, only a small and transient increase in cyclic AMP concentration occurred in response to epinephrine. Activation of phosphorylase kinase was considerably less than that observed in the beating heart. This suggested that an excess of K+ interfered with the action of epinephrine at a site at or before adenyl cyclase.

Thus the activation of phosphorylase in cardiac muscle can be the consequence of one of the following events: (a) the activation of phosphorylase kinase as a result of a rise in cyclic AMP concentration; (b) an increase in the catalytic activity of phosphorylase kinase as a result of an increase in the concentration of Ca++ available to the enzyme; or (c) a combination of these two mechanisms.

  • Copyright ©, 1968, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 4, Issue 5
1 Sep 1968
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Potassium and Calcium Ions in the Effect of Epinephrine on Cardiac Cyclic Adenosine 3',5'-Monophosphate, Phosphorylase Kinase, and Phosphorylase
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Role of Potassium and Calcium Ions in the Effect of Epinephrine on Cardiac Cyclic Adenosine 3',5'-Monophosphate, Phosphorylase Kinase, and Phosphorylase

DONALD H. NAMM, STEVEN E. MAYER and MARGARET MALTBIE
Molecular Pharmacology September 1, 1968, 4 (5) 522-530;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Role of Potassium and Calcium Ions in the Effect of Epinephrine on Cardiac Cyclic Adenosine 3',5'-Monophosphate, Phosphorylase Kinase, and Phosphorylase

DONALD H. NAMM, STEVEN E. MAYER and MARGARET MALTBIE
Molecular Pharmacology September 1, 1968, 4 (5) 522-530;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effects of Small Molecule Ligands on ACKR3 Receptors
  • Michaelis-Menten Quantification of GPCR-G Protein Signaling
  • Anti-aromatase activity of exemestane phase II metabolites
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics